Notably, the enrichment of the PI3K–Akt signaling pathway and Alzheimer's disease‐related pathways indicates that these targets may play a crucial role in the context of neurodegenerative diseases. This evidence concerns the gene AKT1 and early-onset autosomal dominant Alzheimer disease.